Diana Brainard is the founder of AlloVir. AlloVir has raised $427M in total funding. Latest round: IPO. Backed by Fidelity Investments.
Diana Brainard is a virology leader who previously served as Gilead's virology lead and was a developer of remdesivir. She joined AlloVir to run the company as its leader, less than a year after the company completed a $276 million upsized IPO to fund allogeneic T-cell treatments for viral diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library